These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26538208)

  • 21. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
    Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
    Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study).
    Tominaga K; Sakata Y; Kusunoki H; Odaka T; Sakurai K; Kawamura O; Nagahara A; Takeuchi T; Fujikawa Y; Oshima T; Kato M; Furuta T; Murakami K; Chiba T; Miwa H; Kinoshita Y; Higuchi K; Kusano M; Iwakiri R; Fujimoto K; Tack JF; Arakawa T
    Neurogastroenterol Motil; 2018 Jul; 30(7):e13319. PubMed ID: 29498457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
    Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
    Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia.
    Lacy BE; Saito YA; Camilleri M; Bouras E; DiBaise JK; Herrick LM; Szarka LA; Tilkes K; Zinsmeister AR; Talley NJ
    Am J Gastroenterol; 2018 Feb; 113(2):216-224. PubMed ID: 29257140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a randomized placebo-controlled pilot study.
    Yeephu S; Suthisisang C; Suttiruksa S; Prateepavanich P; Limampai P; Russell IJ
    Ann Pharmacother; 2013; 47(7-8):921-32. PubMed ID: 23737510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of the placebo response in functional dyspepsia.
    Talley NJ; Locke GR; Lahr BD; Zinsmeister AR; Cohard-Radice M; D'Elia TV; Tack J; Earnest DL
    Aliment Pharmacol Ther; 2006 Apr; 23(7):923-36. PubMed ID: 16573795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Amitriptyline and Escitalopram on Sleep and Mood in Patients With Functional Dyspepsia.
    Herrick LM; Camilleri M; Schleck CD; Zinsmeister AR; Saito YA; Talley NJ
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):401-406.e2. PubMed ID: 29199141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Herbal Formulation of Jiawei Xiaoyao for the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Placebo-Controlled, Clinical Trial.
    Chen G; Feng P; Wang S; Ding X; Xiong J; Wu J; Wang L; Chen W; Chen G; Han M; Zou T; Li L; Du H
    Clin Transl Gastroenterol; 2020 Oct; 11(10):e00241. PubMed ID: 33108123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of jollab to treat functional dyspepsia: a randomized placebo-controlled clinical trial.
    Pasalar M; Choopani R; Mosaddegh M; Kamalinejad M; Mohagheghzadeh A; Fattahi MR; Ghanizadeh A; Bagheri Lankarani K
    Explore (NY); 2015; 11(3):199-207. PubMed ID: 25777290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
    Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms.
    Theobald DE; Kirsh KL; Holtsclaw E; Donaghy K; Passik SD
    J Pain Symptom Manage; 2002 May; 23(5):442-7. PubMed ID: 12007762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia.
    Talley NJ; Choung RS; Camilleri M; Dierkhising RA; Zinsmeister AR
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1122-31. PubMed ID: 18331462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
    Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
    J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the adrenergic alpha 2a receptor--1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder.
    Lee HY; Kang RH; Paik JW; Jeong YJ; Chang HS; Han SW; Lee MS
    Brain Res; 2009 Mar; 1262():1-6. PubMed ID: 19401164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Open trial of mirtazapine in patients with fibromyalgia.
    Samborski W; Lezanska-Szpera M; Rybakowski JK
    Pharmacopsychiatry; 2004 Jul; 37(4):168-70. PubMed ID: 15467973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized controlled trial.
    Zhang S; Zhao L; Wang H; Wang C; Huang S; Shen H; Wei W; Tao L; Zhou T
    BMC Complement Altern Med; 2013 Mar; 13():54. PubMed ID: 23453018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study.
    Zoccali R; Muscatello MR; Cedro C; Neri P; La Torre D; Spina E; Di Rosa AE; Meduri M
    Int Clin Psychopharmacol; 2004 Mar; 19(2):71-6. PubMed ID: 15076014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.
    Kountouras J; Gavalas E; Papaefthymiou A; Tsechelidis I; Polyzos SA; Bor S; Diculescu M; Jadallah Κ; Tadeusz M; Karakan T; Bochenek Α; Rozciecha J; Dabrowski P; Sparchez Z; Sezgin O; Gülten M; Farsakh NA; Doulberis M
    Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32650518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.